Sign inJoin waitlistJoin the waitlist

Brian Till

Associate Professor, Translational Science and Therapeutics Division, Fred Hutch · University of Washington School of Medicine

Credentials: · · ·

History

University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

University of Washington-Seattle Campus
2005–2008
Internal Medicine
2002–2005
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
1998–2002
Biology, The Catholic University of America
1994–1998

Research

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
Blood · 2008 · First of 16 authors · Corresponding · 585 citations
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
Blood · 2012 · First of 15 authors · Corresponding · 443 citations
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy
Blood · 2019 · 359 citations

Ajay Gopal
52 papers
Mazyar Shadman
43 papers
David Maloney
32 papers
Damian Green
31 papers
Stephen Smith
31 papers
Ryan Cassaday
26 papers · 1 as a fellow
Ryan Lynch
23 papers
Chaitra Ujjani
22 papers
AC
Andrew Cowan
17 papers
Jordan Gauthier
17 papers · 5 as a resident
CT
Cameron Turtle
15 papers
Leona Holmberg
15 papers

Grants

Mechanisms of Treatment Failure in Chimeric Antigen Receptor T Cell Therapy
National Cancer Institute · R01
Contact PI · $2.9M · Fred Hutchinson Cancer Center
2019–2025
Radioimmunotherapy Combinations for B-Cell Malignancy
National Cancer Institute · R01
PI · $1.1M · University of Miami School of Medicine
1998–2020
Optimization of Adoptive Immunotherapy with Autologous CD20-Specific T Cells
National Cancer Institute · K23
Contact PI · $686.9K · Fred Hutchinson Cancer Research Center
2013–2017